Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

V. Saraswat; S. Norris; R. J. de Knegt; J. F. Sanchez Avila; M. Sonderup; E. Zuckerman; P. Arkkila; C. Stedman; S. Acharya; I. Aho; A. C. Anand; M. I. Andersson; V. Arendt; O. Baatarkhuu; K. Barclay; Z. Ben-Ari; C. Bergin; F. Bessone; S. Blach; N. Blokhina; C. R. Brunton; G. Choudhuri; V. Chulanov; L. Cisneros; E. A. Croes; Y. A. Dahgwahdorj; O. Dalgard; J. R. Daruich; N. R. Dashdorj; D. Davaadorj; M. de Vree; C. Estes; R. Flisiak; A. C. Gadano; E. Gane; W. Halota; A. Hatzakis; C. Henderson; P. Hoffmann; J. Hornell; D. Houlihan; S. Hrusovsky; P. Jarčuška; D. Kershenobich; K. Kostrzewska; P. Kristian; M. Leshno; Y. Lurie; A. Mahomed; N. Mamonova; N. Mendez-Sanchez; J. Mossong; E. Nurmukhametova; P. Nymadawa; M. Oltman; J. Oyunbileg; Ts Oyunsuren; G. Papatheodoridis; N. Pimenov; N. Prabdial-Sing; M. [= Maria] Prins; P. Puri; S. Radke; A. Rakhmanova; H. Razavi; K. Razavi-Shearer; H. W. Reesink; E. Ridruejo; R. Safadi; O. Sagalova; R. Sanduijav; I. Schréter; C. Seguin-Devaux; S. R. Shah; I. Shestakova; A. Shevaldin; O. Shibolet; S. Sokolov; K. Souliotis; C. W. Spearman; T. Staub; E. A. Strebkova; D. Struck; K. Tomasiewicz; L. Undram; A. J. van der Meer; D. van Santen; I. Veldhuijzen; F. G. Villamil; S. Willemse; F. R. Zuure; M. O. Silva; V. Sypsa; E. Gower

doi:10.1111/jvh.12350

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

V. Saraswat
, S. Norris
, R. J. de Knegt
, J. F. Sanchez Avila
, M. Sonderup
, E. Zuckerman
, P. Arkkila
, C. Stedman
, S. Acharya
, I. Aho
, A. C. Anand
, M. I. Andersson
, V. Arendt
, O. Baatarkhuu
, K. Barclay
, Z. Ben-Ari
, C. Bergin
, F. Bessone
, S. Blach
, N. Blokhina

C. R. Brunton, G. Choudhuri, V. Chulanov, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, M. de Vree, C. Estes, R. Flisiak, A. C. Gadano, E. Gane, W. Halota, A. Hatzakis, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, J. Mossong, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. [= Maria] Prins, P. Puri, S. Radke, A. Rakhmanova, H. Razavi, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, R. Sanduijav, I. Schréter, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, S. Sokolov, K. Souliotis, C. W. Spearman, T. Staub, E. A. Strebkova, D. Struck, K. Tomasiewicz, L. Undram, A. J. van der Meer, D. van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, F. R. Zuure, M. O. Silva, V. Sypsa, E. Gower

Research output: Contribution to journal › Article › Academic › peer-review

23 Downloads (Pure)

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available

Original language	English
Pages (from-to)	6-25
Journal	Journal of viral hepatitis
Volume	22
Issue number	Suppl. 1
DOIs	https://doi.org/10.1111/jvh.12350
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/jvh.12350

Historical-epidemiology-of-hepatitis-c-virus-hcv-in-select-countries---volume-2.pdfFinal published version, 1.37 MBLicence: Taverne

Cite this

Saraswat, V., Norris, S., de Knegt, R. J., Sanchez Avila, J. F., Sonderup, M., Zuckerman, E., Arkkila, P., Stedman, C., Acharya, S., Aho, I., Anand, A. C., Andersson, M. I., Arendt, V., Baatarkhuu, O., Barclay, K., Ben-Ari, Z., Bergin, C., Bessone, F., Blach, S., ... Gower, E. (2015). Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. Journal of viral hepatitis, 22(Suppl. 1), 6-25. https://doi.org/10.1111/jvh.12350

@article{9df9188f056e45a3b752d4403276be20,

title = "Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2",

abstract = "Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13\% in the Netherlands to 2.91\% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available",

author = "V. Saraswat and S. Norris and \{de Knegt\}, \{R. J.\} and \{Sanchez Avila\}, \{J. F.\} and M. Sonderup and E. Zuckerman and P. Arkkila and C. Stedman and S. Acharya and I. Aho and Anand, \{A. C.\} and Andersson, \{M. I.\} and V. Arendt and O. Baatarkhuu and K. Barclay and Z. Ben-Ari and C. Bergin and F. Bessone and S. Blach and N. Blokhina and Brunton, \{C. R.\} and G. Choudhuri and V. Chulanov and L. Cisneros and Croes, \{E. A.\} and Dahgwahdorj, \{Y. A.\} and O. Dalgard and Daruich, \{J. R.\} and Dashdorj, \{N. R.\} and D. Davaadorj and \{de Vree\}, M. and C. Estes and R. Flisiak and Gadano, \{A. C.\} and E. Gane and W. Halota and A. Hatzakis and C. Henderson and P. Hoffmann and J. Hornell and D. Houlihan and S. Hrusovsky and P. Jar{\v c}u{\v s}ka and D. Kershenobich and K. Kostrzewska and P. Kristian and M. Leshno and Y. Lurie and A. Mahomed and N. Mamonova and N. Mendez-Sanchez and J. Mossong and E. Nurmukhametova and P. Nymadawa and M. Oltman and J. Oyunbileg and Ts Oyunsuren and G. Papatheodoridis and N. Pimenov and N. Prabdial-Sing and Prins, \{M. [= Maria]\} and P. Puri and S. Radke and A. Rakhmanova and H. Razavi and K. Razavi-Shearer and Reesink, \{H. W.\} and E. Ridruejo and R. Safadi and O. Sagalova and R. Sanduijav and I. Schr{\'e}ter and C. Seguin-Devaux and Shah, \{S. R.\} and I. Shestakova and A. Shevaldin and O. Shibolet and S. Sokolov and K. Souliotis and Spearman, \{C. W.\} and T. Staub and Strebkova, \{E. A.\} and D. Struck and K. Tomasiewicz and L. Undram and \{van der Meer\}, \{A. J.\} and \{van Santen\}, D. and I. Veldhuijzen and Villamil, \{F. G.\} and S. Willemse and Zuure, \{F. R.\} and Silva, \{M. O.\} and V. Sypsa and E. Gower",

year = "2015",

doi = "10.1111/jvh.12350",

language = "English",

volume = "22",

pages = "6--25",

journal = "Journal of viral hepatitis",

issn = "1352-0504",

publisher = "Wiley Blackwell",

number = "Suppl. 1",

}

Saraswat, V, Norris, S, de Knegt, RJ, Sanchez Avila, JF, Sonderup, M, Zuckerman, E, Arkkila, P, Stedman, C, Acharya, S, Aho, I, Anand, AC, Andersson, MI, Arendt, V, Baatarkhuu, O, Barclay, K, Ben-Ari, Z, Bergin, C, Bessone, F, Blach, S, Blokhina, N, Brunton, CR, Choudhuri, G, Chulanov, V, Cisneros, L, Croes, EA, Dahgwahdorj, YA, Dalgard, O, Daruich, JR, Dashdorj, NR, Davaadorj, D, de Vree, M, Estes, C, Flisiak, R, Gadano, AC, Gane, E, Halota, W, Hatzakis, A, Henderson, C, Hoffmann, P, Hornell, J, Houlihan, D, Hrusovsky, S, Jarčuška, P, Kershenobich, D, Kostrzewska, K, Kristian, P, Leshno, M, Lurie, Y, Mahomed, A, Mamonova, N, Mendez-Sanchez, N, Mossong, J, Nurmukhametova, E, Nymadawa, P, Oltman, M, Oyunbileg, J, Oyunsuren, T, Papatheodoridis, G, Pimenov, N, Prabdial-Sing, N, Prins, MM, Puri, P, Radke, S, Rakhmanova, A, Razavi, H, Razavi-Shearer, K, Reesink, HW, Ridruejo, E, Safadi, R, Sagalova, O, Sanduijav, R, Schréter, I, Seguin-Devaux, C, Shah, SR, Shestakova, I, Shevaldin, A, Shibolet, O, Sokolov, S, Souliotis, K, Spearman, CW, Staub, T, Strebkova, EA, Struck, D, Tomasiewicz, K, Undram, L, van der Meer, AJ, van Santen, D, Veldhuijzen, I, Villamil, FG, Willemse, S, Zuure, FR, Silva, MO, Sypsa, V & Gower, E 2015, 'Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2', Journal of viral hepatitis, vol. 22, no. Suppl. 1, pp. 6-25. https://doi.org/10.1111/jvh.12350

TY - JOUR

T1 - Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

AU - Saraswat, V.

AU - Norris, S.

AU - de Knegt, R. J.

AU - Sanchez Avila, J. F.

AU - Sonderup, M.

AU - Zuckerman, E.

AU - Arkkila, P.

AU - Stedman, C.

AU - Acharya, S.

AU - Aho, I.

AU - Anand, A. C.

AU - Andersson, M. I.

AU - Arendt, V.

AU - Baatarkhuu, O.

AU - Barclay, K.

AU - Ben-Ari, Z.

AU - Bergin, C.

AU - Bessone, F.

AU - Blach, S.

AU - Blokhina, N.

AU - Brunton, C. R.

AU - Choudhuri, G.

AU - Chulanov, V.

AU - Cisneros, L.

AU - Croes, E. A.

AU - Dahgwahdorj, Y. A.

AU - Dalgard, O.

AU - Daruich, J. R.

AU - Dashdorj, N. R.

AU - Davaadorj, D.

AU - de Vree, M.

AU - Estes, C.

AU - Flisiak, R.

AU - Gadano, A. C.

AU - Gane, E.

AU - Halota, W.

AU - Hatzakis, A.

AU - Henderson, C.

AU - Hoffmann, P.

AU - Hornell, J.

AU - Houlihan, D.

AU - Hrusovsky, S.

AU - Jarčuška, P.

AU - Kershenobich, D.

AU - Kostrzewska, K.

AU - Kristian, P.

AU - Leshno, M.

AU - Lurie, Y.

AU - Mahomed, A.

AU - Mamonova, N.

AU - Mendez-Sanchez, N.

AU - Mossong, J.

AU - Nurmukhametova, E.

AU - Nymadawa, P.

AU - Oltman, M.

AU - Oyunbileg, J.

AU - Oyunsuren, Ts

AU - Papatheodoridis, G.

AU - Pimenov, N.

AU - Prabdial-Sing, N.

AU - Prins, M. [= Maria]

AU - Puri, P.

AU - Radke, S.

AU - Rakhmanova, A.

AU - Razavi, H.

AU - Razavi-Shearer, K.

AU - Reesink, H. W.

AU - Ridruejo, E.

AU - Safadi, R.

AU - Sagalova, O.

AU - Sanduijav, R.

AU - Schréter, I.

AU - Seguin-Devaux, C.

AU - Shah, S. R.

AU - Shestakova, I.

AU - Shevaldin, A.

AU - Shibolet, O.

AU - Sokolov, S.

AU - Souliotis, K.

AU - Spearman, C. W.

AU - Staub, T.

AU - Strebkova, E. A.

AU - Struck, D.

AU - Tomasiewicz, K.

AU - Undram, L.

AU - van der Meer, A. J.

AU - van Santen, D.

AU - Veldhuijzen, I.

AU - Villamil, F. G.

AU - Willemse, S.

AU - Zuure, F. R.

AU - Silva, M. O.

AU - Sypsa, V.

AU - Gower, E.

PY - 2015

Y1 - 2015

N2 - Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available

AB - Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available

U2 - 10.1111/jvh.12350

DO - 10.1111/jvh.12350

M3 - Article

C2 - 25560839

SN - 1352-0504

VL - 22

SP - 6

EP - 25

JO - Journal of viral hepatitis

JF - Journal of viral hepatitis

IS - Suppl. 1

ER -

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this